Seres Therapeutics (MCRB) Other Gross PP&E Adjustments: 2015-2025
Historic Other Gross PP&E Adjustments for Seres Therapeutics (MCRB) over the last 11 years, with Sep 2025 value amounting to -$9.7 million.
- Seres Therapeutics' Other Gross PP&E Adjustments rose 46.53% to -$9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$80.6 million, marking a year-over-year increase of 39.69%. This contributed to the annual value of -$45.0 million for FY2024, which is 9.33% up from last year.
- Seres Therapeutics' Other Gross PP&E Adjustments amounted to -$9.7 million in Q3 2025, which was up 17.95% from -$11.8 million recorded in Q2 2025.
- In the past 5 years, Seres Therapeutics' Other Gross PP&E Adjustments ranged from a high of $44.5 million in Q3 2021 and a low of -$63.0 million during Q4 2022.
- For the 3-year period, Seres Therapeutics' Other Gross PP&E Adjustments averaged around -$29.6 million, with its median value being -$34.2 million (2024).
- Per our database at Business Quant, Seres Therapeutics' Other Gross PP&E Adjustments crashed by 363.04% in 2022 and then surged by 62.61% in 2025.
- Seres Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $24.0 million in 2021, then tumbled by 363.04% to -$63.0 million in 2022, then increased by 21.24% to -$49.6 million in 2023, then grew by 9.33% to -$45.0 million in 2024, then spiked by 46.53% to -$9.7 million in 2025.
- Its Other Gross PP&E Adjustments was -$9.7 million in Q3 2025, compared to -$11.8 million in Q2 2025 and -$14.0 million in Q1 2025.